Clinical characteristics of the subjects for the analyses regarding the risk of NAFLD.

<p>The data are the means ± standard deviation, median (range) for skewed variables, or the numbers of subjects (%) for categorical variables.</p><p>^a Fisher’s exact test.</p><p>^b Mann–Whitney U test (otherwise, Student’s t-test was used).</p><p>NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; PNPLA3, patatin-like phospholipase 3.</p><p>Clinical characteristics of the subjects for the analyses regarding the risk of NAFLD.</p

The longitudinal changes in the prevalence of NAFLD stratified by the <i>PNPLA3</i> genotype among normal weight subjects.

<p>The prevalence of NAFLD is shown as solid, dashed-dotted and dotted lines in the subjects with the <i>PNPLA3</i> C/C, C/G and G/G genotypes, respectively. NAFLD, non-alcoholic fatty liver disease; PNPLA3, patatin-like phospholipase 3.</p

Comparison of Risk Prediction Models before and after adding <i>H</i>. <i>pylori</i> and IL-1 polymorphisms.

<p>Comparison of Risk Prediction Models before and after adding <i>H</i>. <i>pylori</i> and IL-1 polymorphisms.</p

Prevalence of STEMI according to the current smoke exposure and the coincidence of <i>Helicobacter pylori</i> seropositivity and interleukin-1 polymorphisms.

<p>STEMI, ST-segment elevation myocardial infarction.</p

Clinical characteristics according to simultaneous presence of <i>H</i>. <i>pylori</i> and IL-1 polymorphisms.

<p>Clinical characteristics according to simultaneous presence of <i>H</i>. <i>pylori</i> and IL-1 polymorphisms.</p

Logistic regression analysis for STEMI.

<p>Logistic regression analysis for STEMI.</p

Prevalence of the coincidence of <i>Helicobacter pylori</i> seropositivity and interleukin-1 polymorphisms between NSTE-ACS and STEMI groups.

<p>NSTE-ACS, non-ST-segment elevation acute coronary syndrome; STEMI, ST-segment elevation myocardial infarction.</p

Logistic regression analysis for STEMI.

<p>Logistic regression analysis for STEMI.</p